AFL Aflac
Dominant Japan cancer insurer printing cash, quietly buying back a third of itself.
The business
Aflac sells supplemental insurance — policies that pay cash directly to policyholders when they suffer a covered illness or injury, filling gaps left by primary health coverage. The core franchise is Japan (roughly 70% of earnings), where Aflac is the #1 cancer insurer by a wide margin, plus a U.S. supplemental business. Premiums are predictable, claims are actuarially stable, and the float is invested in high-grade fixed income.
Quality gate · 88/100
Moat & management
| Moat | wide moat |
| Source | brand |
| Trajectory | stable |
| Management | excellent |
In Japan, Aflac's cancer insurance brand is essentially synonymous with the category — decades of distribution through Japan Post and thousands of bank branches create formidable switching costs and shelf-space dominance that a new entrant cannot replicate quickly. In the U.S., the worksite distribution model and employer relationships create sticky renewals. The supplemental niche is also structurally underserved by primary insurers, giving Aflac a durable lane with little competitive overlap.
The -5.5% annual share-count CAGR is one of the most consistent buyback records in insurance — management has retired roughly a third of shares outstanding over a decade at sensible prices, and the dividend has been raised for 40+ consecutive years. Capital allocation is disciplined: no transformative acquisitions, conservative investment portfolio, and leverage that is modest for a large insurer.
Owner-earnings inputs
| Owner earnings (TTM) | 4.64B |
| Owner-earnings yield | 7.6% |
| Free-cash-flow yield | 4.8% |
| Growth used (normalized) | 5.0% |
| Terminal growth | 3.0% |
| Discount rate (hurdle) | 7.1% |
Key risks
- Yen depreciation structurally reduces Japan earnings when translated to USD — a sustained weak yen is a permanent headwind, not a timing issue
- Japan's aging, shrinking population limits new policy growth; the existing in-force block runs off slowly over decades
- Regulatory or distribution-channel changes in Japan (e.g., Japan Post restructuring) could disrupt the dominant bancassurance model
Catalysts
- Yen normalization from current weak levels would meaningfully lift reported earnings and intrinsic value in USD terms
- U.S. supplemental segment growing faster as employer-paid benefits shift costs to workers, expanding the addressable market
Recent news
score · 8 articles
- UNM Outperforms Industry, Trades Near 52-Week High: Time to Exit?
- MarketBeat Week in Review – 06/08 - 06/12
- The “Duck Stock” Keeps Quietly Making Money for Shareholders
- How Aflac (AFL) Investors Can Read A Steady Target And Evolving Company Story
- Globe Life Hits 52-Week High: Time to Add the Stock for Solid Returns?
- Aflac Stock: Is AFL Outperforming the Financial Sector?
- Piper Sandler Raises Aflac (AFL) Price Target, Favors Insurance Carriers over Brokers
- Why Is Aflac (AFL) Down 0.9% Since Last Earnings Report?
⚠ financial — owner earnings ≈ net income · financial — valued by residual income (ROE vs cost of equity on book equity)